AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home Mycology Article
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Article | Open Access

Studies on the antifungal and serotonin receptor agonist activities of the secondary metabolites from piezotolerant deep-sea fungus Ascotricha sp.

A. Ganesh Kumara( )K. BalamuruganbR. Vijaya RaghavanaG. DharaniaR. Kirubagarana
Marine Biotechnology Division, Ocean Science and Technology for Islands Group, ESSO – National Institute of Ocean Technology, Ministry of Earth Sciences (MoES), Government of India, Chennai, Tamilnadu, India
Department of Biotechnology, Alagappa University, Karaikudi, Tamilnadu, India
Show Author Information

Abstract

The potent antifungal agent sesquiterpenes and serotonin 5-HT2C agonist ascotricin were produced by a newly isolated deep-sea fungus Ascotricha sp. This fungus was isolated from deep-sea sediment collected at a depth of 1235 m and characterized. Piezotolerance was successfully tested under high pressure-low temperature (100 bar pressure and 20℃) microbial cultivation system. Production of secondary metabolites was enhanced at optimized culture conditions. The in-vivo antifungal activity of sesquiterpenes was studied using the Caenorhabditis elegans – Candida albicans model system. The sesquiterpenes affected the virulence of C. albicans and prolonged the life of the host C. elegans. These findings suggest that sesquiterpenes are attractive antifungal drug candidates. The 5-HT2C receptor agonist is a potential target for the development of drugs for a range of central nervous system disorders. The interaction of 5-HT2C agonist ascotricin with the receptor was studied through bioinformatic analysis. The in silico molecular docking and molecular dynamic simulation studies demonstrated that they fit into the serotonin 5-HT2C active site and the crucial amino acid residues involved in the interactions were identified. To our knowledge, this is first report of in vivo antifungal analysis of sesquiterpenes and in silico studies of serotonin 5-HT2C receptor-ascotricin complex.

References

 

Abe F, Kato C, Horikoshi K. 1999. Pressure-regulated metabolism in microorganisms. Trends Microbiol. 7:447–453.

 

Anastassopoulou CG, Fuchs BB, Mylonakis E. 2011. Caenorhabditis elegans-based model systems for antifungal drug discovery. Curr Pharm Des. 1:1225–1233.

 

Bhadury P, Bik H, Lambshead JD, Austen MC, Smerdon GR, Rogers AD. 2011. Molecular diversity of fungal phylotypes co-amplified alongside nematodes from coastal and deep-sea marine environments. PLoS One. 6:1–8.

 

Bhattacharyya PN, Jha DK. 2011. Optimization of cultural conditions affecting growth and improved bioactive metabolite production by a subsurface Aspergillus strain TSF 146. Int J Appl Biol Pharm Technol. 2:133–145.

 

Breger J, Fuchs BB, Aperis G, Moy TI, Ausubel FM, Mylonakis E. 2007. Antifungal chemical compounds identified using C. elegans pathogenicity assay. PLoS Pathog. 3:1–11.

 

Brenner S. 1974. The genetics of Caenorhabditis elegans. Genetics. 77:71–94.

 

Calvo AM, Wilson RA, Bok JW, Keller NP. 2002. Relationship between secondary metabolism and fungal development. Microbiol Mol Biol Rev. 66:447–459.

 

Clinton EC, Drake M, Daniel F, Krishnakanth K, Neil ER, Klimberly LR, Rajeev S, Raymond GB. 2014. A novel aminotetralin-type serotonin (5-HT)2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses. J Pharmacol Exp Ther. 349:310–318.

 

Demain AL, Sanchez S. 2009. Microbial drug discovery: 80 years of progress. J Antibiot. 62:5–16.

 

Durai S, Vigneshwari L, Balamurugan K. 2013. Caenorhabditis elegans-based in vivo screening of bioactives from marine sponge-associated bacteria against Vibrio alginolyticus. J Appl Microbiol. 115:1329–1342.

 

Elias BC, Said S, de Albuquerque S, Pupo MT. 2006. The influence of culture conditions on the biosynthesis of secondary metabolites by Penicillium verrucosum Dierck. Microbiol Res. 161:273–280.

 

Elsebai MF, Kehraus S, Gütschow M, König GM. 2010. Spartinoxide, a new enantiomer of A82775C with inhibitiory activity toward HLE from the marine-derived fungus Phaeosphaeria spatinae. Nat Prod Commun. 5:1071–1076.

 

Ganesh Kumar A, Senthil Kumar S, Joshi G, Dharani G, Kirubagaran R. 2015. Production and characterization of bioactive metabolites from piezotolerant deep sea fungus Nigrospora sp. in submerged fermentation. J Appl Microbiol. 118:99–111.

 

Gao L, Sun MH, Liu XZ, Che YS. 2007. Effects of carbon concentration and carbon to nitrogen ratio on the growth and sporulation of several biocontrol fungi. Mycol Res. 111:87–92.

 

Hall TA. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser. 41:95–98.

 

Higgins GA, Sellers EM, Fletcher PJ. 2013. From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists. Trends Pharmcol Sci. 34:560–570.

 

Hoyer D, Hannon JP, Martin GR. 2002. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav. 71:533–554.

 

Huang G. 2012. Regulation of phenotypic transitions in the fungal pathogen Candida albicans. Virulence. 3:251–261.

 

Huang H, Feng X, Xiao Z, Liu L, Li H, Ma L, Lu Y, Ju J, She Z, Lin Y. 2011. Azaphilones and p-terphenyls from the mangrove endophytic fungus Penicillium chermesinum (Zh4-E2) isolated from the South China Sea. J Nat Prod. 74:997–1002.

 

Klich MA. 2007. Aspergillus flavus: the major producer of aflatoxin. Mol Plant Pathol. 8:713–722.

 

Lambert HW, Lauder JM. 1999. Serotonin receptor agonists that increase cyclic AMP positively regulate IGF-Ⅰ in mouse mandibular mesenchymal cells. Dev Neurosci. 21:105–112.

 

Leet JE, Huang S, Klohr SE, McBrien KD. 1996. Ascosteroside, a new antifungal agent from Ascotricha amphitricha. Ⅱ. Isolation and structure elucidation. J Antibiot (Tokyo). 49:553–559.

 

Li JW, Vederas JC. 2009. Drug discovery and natural products: end of an era or an endless frontier. Science. 325:161–165.

 

Lin X, Zhou X, Wang F, Liu K, Yang B, Yang X, Peng Y, Liu J, Ren Z, Liu Y. 2012. A new cytotoxic sesquiterpene quinone produced by Penicillium sp. F00120 isolated from a deep sea sediment sample. Mar Drugs. 10:106–115.

 

Liu H, Edrada-Ebel R, Ebel R, Wang Y, Schulz B, Draeger S, Müller WE, Wray LW, Proksch P. 2009. Drimane sesquiterpenoids from the fungus Aspergillus ustus isolated from the marine sponge Suberites domuncula. J Nat Prod. 72:1585–1588.

 

Lu Z, Zhu H, Fu P, Wang Y, Zhang Z, Lin H, Liu P, Zhuang Y, Hong K, Zhu W. 2010. Cytotoxic polyphenols from the marine-derived fungus Penicillium expansum. J Nat Prod. 73:911–914.

 

Lucio AK, Polizeli ML, Jorge JA, Terenzi HF. 2000. Stimulation of hyphal growth in anaerobic cultures of Mucor rouxii by extracellular trehalose. Relevance of cell wall-bound activity of acid trehalase for trehalose utilization. FEMS Microbiol Lett. 182:9–13.

 

Merlin JN, Nimal IVS, Christhuda S, Praveen KP, Agastian P. 2013. Optimization of growth and bioactive metabolite production: fusarium solani. Asian J Pharm Clin Res. 6:98–103.

 

Miao L, Kwong TF, Qian PY. 2006. Effect of culture conditions on mycelial growth, antibacterial activity, and metabolite profiles of the marine-derived fungus Arthrinium c.f. saccharicola. Appl Microbiol Biotechnol. 72:1063–1073.

 

Murti Y, Agarwal T. 2010. Marine derived pharmaceuticals-development of natural health products from marine biodiversity. Int J ChemTech Res. 2:2198–2217.

 
[NCCLS]National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Wayne PA: Approved standard M27-A.
 

Neelamegam R, Hellenbrand T, Schroeder FA, Wang C, Hooker JM. 2014. Imaging evaluation of 5HT2C agonists, [(11)C]WAY-163909 and [(11)C]vabicaserin, formed by Pictet-Spengler cyclization. J Med Chem. 57:1488–1494.

 

Sanglard D. 2016. Emerging threats in antifungal-resistant fungal pathogens. Front Med (Lausanne). 3:1–10.

 

Sanguinetti M, Posteraro B, Lass-Flörl C. 2015. Antifungal drug resistance among Candida species: mechanisms and clinical impact. Mycoses. 58:2–13.

 

Souza MT, Almeida JR, Araujo AA, Duarte MC, Gelain DP, Moreira JC, Dos Santos MR, Quintans-Júnior LJ. 2014. Structure–activity relationship of terpenes with anti-inflammatory profile – a systematic review. Basic Clin Pharmacol Toxicol. 115:244–256.

 

Sudbery PE. 2011. Growth of Candida albicans hyphae. Nature Rev Microbiol. 9:737–748.

 

Tamminen A, Wang Y, Wiebe MG. 2015. Production of calcaride A by Calcarisporium sp. in shaken flasks and stirred bioreactors. Mar Drugs. 13:3992–4005.

 

Van Der Linden JW, Warris A, Verweij PE. 2011. Aspergillus species intrinsically resistant to antifungal agents. Med Mycol. 49:1–8.

 

Wang L, Li M, Tang J, Li X. 2016. Eremophilane sesquiterpenes from a deep marine-derived fungus, Aspergillus sp. SCSIOW2, cultivated in the presence of epigenetic modifying agents. Molecules. 21:1–13.

 

Wang WJ, Li DY, Li YC, Hua HM, Ma EL, Li ZL. 2014a. Caryophyllene sesquiterpenes from the marine-derived fungus Ascotricha sp. ZJ-M-5 by the one strain-many compounds strategy. J Nat Prod. 77:1367–1371.

 

Wang Y, Zhang WP, Cao HL, Shek CS, Tian RM, Wong YH, Batang Z, Al-Suwailem A, Qian PY. 2014b. Diversity and distribution of eukaryotic microbes in and around a brine pool adjacent to the Thuwal cold seeps in the Red Sea. Front Microbiol. 5:1–10.

 

Wang YT, Xue YR, Liu CH. 2015. A brief review of bioactive metabolites derived from deep-sea fungi. Mar Drugs. 13:4594–4616.

 

Wu G, Lin A, Gu Q, Zhu T, Li D. 2013. Four new chloro-eremophilane sesquiterpenes from an antarctic deep-sea derived fungus, Penicillium sp. PR19N-1. Mar Drugs. 11:1399–1408.

 

Yonesu K, Ohnuki T, Ono Y, Takatsu T, Nara F. 2009. Ascotricins A and B, novel antagonists of sphingosine-1-phosphate receptor 1 from Ascotricha chartarum Berk. SANK 14186. J Antibiot (Tokyo). 62:359–364.

Mycology
Pages 92-108
Cite this article:
Kumar AG, Balamurugan K, Raghavan RV, et al. Studies on the antifungal and serotonin receptor agonist activities of the secondary metabolites from piezotolerant deep-sea fungus Ascotricha sp.. Mycology, 2019, 10(2): 92-108. https://doi.org/10.1080/21501203.2018.1541934

197

Views

5

Crossref

2

Web of Science

3

Scopus

Altmetrics

Received: 06 September 2018
Accepted: 23 October 2018
Published: 21 November 2018
© 2018 The Author(s).

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Return